ALKS vs MCK · P/E 14, rev $1.56B vs P/E 20, rev $403.43B
Alkermes Plc (ALKS) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the ALKS and MCK stock pages for the full models.
Not investment advice.